Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-06-20
1987-10-27
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548301, A61K 31415, C07D23338
Patent
active
047030542
ABSTRACT:
The invention relates to 4-imidazolidinone derivatives which help restore learning and memory difficulties associated with ageing. A compound of the invention is 1-(2-aminoacetyl)-2,2-dimethyl-4-imidazolidinone, of the formula: ##STR1##
REFERENCES:
patent: 3428646 (1969-02-01), Hellerbach
V. Klixkull et al, Int'l. J. of Pharm., 20, 273-284 (1984).
Chem. Abstracts, 94, 121894u (1981).
Chem. Abstracts, 63, 2978h (1965).
P. Hardy, et al., J. Chem. Soc. Perkin I, 1954-1960 (1977).
Y. Ariyoshi, et al., Bull. Chem. Soc. Japan, 45, 2015-2018 (1972).
C. Panetta, et al., J. Org. Chem., 37, 302-304 (1972).
F. Cardinaux, et al., Helv. Chim. Acta, 56, 339-347 (1973).
Banfi Silvano
Farina Carlo
Pfeiffer Ugo
Pinza Mario
ISF S.p.A.
Lourie Alan D.
Mayer Nancy S.
Schwartz Richard A.
Suter Stuart R.
LandOfFree
Nootropic imidazolidinones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nootropic imidazolidinones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nootropic imidazolidinones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1272449